News - MedImmune, Biotechnology


Current filters:


Popular Filters

Heptares meets milestone in MedImmune research collaboration

Heptares meets milestone in MedImmune research collaboration


UK-based drug company Heptares Therapeutics has successfully completed the research phase of its antibody…

AstraZenecaBiotechnologyHeptares TherapeuticsMedImmuneResearchUK

AstraZeneca in deal with Immunocore to develop novel cancer therapies

AstraZeneca in deal with Immunocore to develop novel cancer therapies


UK privately-held biotech firm Immunocore has signed an oncology research collaboration and licensing…


AstraZeneca unit links with NGM Biopharma on diabetes and obesity research


Anglo-Swedish drug major AstraZeneca's (LSE: AZN) US biologics R&D subsidiary MedImmune has entered into…

AstraZenecaBiotechnologyDiabetesLicensingMedImmuneMetabolicsNGM BiopharmaceuticalsPharmaceuticalResearch

AstraZeneca plans to move three cancer drug candidates into Ph III


Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning (May 16) announced that it will be moving…

AstraZenecaBiotechnologyMedImmunemoxetumomab pasudotoxolaparibOncologyPharmaceuticalResearchselumetinib

Evotec acquires Cell Culture Service GmbH; expands deal with AstraZeneca


German biotech firm Evotec (EVT: TecDAX) has acquired all the shares in Cell Culture Service GmbH (CCS),…

AstraZenecaBiotechnologyCell Culture Service GmbHDiabetesEvotecLicensingMedImmuneMergers & AcquisitionsPharmaceutical

iBio uses iBioLaunch technology to produce functional MAb copy of Synagis


US biotech firm iBio (NYSE AMEX: IBIO) says that its proprietary iBioLaunch technology for the production…

AstraZenecaBiotechnologyiBIOMedImmunePalivizumabResearchRespiratory and PulmonarySynagis

AgonOx partners with AstraZeneca unit for development of OX40 agonists in cancer therapy


USA-based AgonOx has entered into an exclusive global partnership with MedImmune, the global biologics…


Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top